First Citizens Bank & Trust CO Amgen Inc Transaction History

First Citizens Bank & Trust CO

$6.53 Billion
Q3 2024

A detailed history of First Citizens Bank & Trust CO transactions in Amgen Inc stock. As of the latest transaction made, First Citizens Bank & Trust CO holds 10,054 shares of AMGN stock, worth $3.18 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

10,054

Previous 9,557 5.2%

Holding current value

$3.18 Million

Previous $2.99 Million 8.47%

% of portfolio

0.05%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$309.38 - $337.38 $153,761 - $167,677	497 Added 5.2%	10,054 $3.24 Million
Q2 2024 Jul 19, 2024	BUY	$262.75 - $319.31 $1,839 - $2,235	7 Added 0.07%	9,557 $2.99 Million
Q1 2024 Apr 15, 2024	BUY	$268.87 - $324.56 $801,232 - $967,188	2,980 Added 45.36%	9,550 $2.72 Million
Q4 2023 Jan 22, 2024	BUY	$255.7 - $288.46 $113,019 - $127,499	442 Added 7.21%	6,570 $1.89 Million
Q3 2023 Oct 30, 2023	SELL	$218.65 - $271.46 $75,652 - $93,925	-346 Reduced 5.34%	6,128 $1.65 Million
Q2 2023 Aug 15, 2023	BUY	$214.27 - $253.37 $923,932 - $1.09 Million	4,312 Added 199.44%	6,474 $1.44 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $28,901 - $35,225	-128 Reduced 5.59%	2,162 $522,000
Q4 2022 Jan 24, 2023	SELL	$229.03 - $291.01 $55,196 - $70,133	-241 Reduced 9.52%	2,290 $601,000
Q3 2022 Oct 20, 2022	SELL	$224.46 - $253.15 $3,815 - $4,303	-17 Reduced 0.67%	2,531 $570,000
Q2 2022 Jul 26, 2022	BUY	$230.71 - $256.74 $148,577 - $165,340	644 Added 33.82%	2,548 $620,000
Q1 2022 Apr 26, 2022	SELL	$219.27 - $242.57 $1,096 - $1,212	-5 Reduced 0.26%	1,904 $460,000
Q4 2021 Mar 11, 2022	SELL	$198.88 - $227.6 $24,263 - $27,767	-122 Reduced 6.01%	1,909 $429,000
Q3 2021 Oct 15, 2021	SELL	$212.27 - $248.7 $56,463 - $66,154	-266 Reduced 11.58%	2,031 $431,000
Q2 2021 Jul 14, 2021	SELL	$233.58 - $259.14 $344,997 - $382,749	-1,477 Reduced 39.14%	2,297 $560,000
Q1 2021 Apr 14, 2021	SELL	$221.91 - $258.6 $12,648 - $14,740	-57 Reduced 1.49%	3,774 $939,000
Q4 2020 Jan 13, 2021	SELL	$216.38 - $257.67 $43,708 - $52,049	-202 Reduced 5.01%	3,831 $880,000
Q3 2020 Oct 15, 2020	BUY	$234.65 - $260.95 $48,807 - $54,277	208 Added 5.44%	4,033 $1.03 Million
Q2 2020 Jul 15, 2020	SELL	$197.81 - $242.74 $401,356 - $492,519	-2,029 Reduced 34.66%	3,825 $903,000
Q1 2020 Apr 17, 2020	SELL	$182.24 - $241.7 $105,699 - $140,186	-580 Reduced 9.01%	5,854 $1.19 Million
Q4 2019 Jan 15, 2020	SELL	$189.21 - $243.2 $95,551 - $122,816	-505 Reduced 7.28%	6,434 $1.55 Million
Q3 2019 Oct 18, 2019	BUY	$174.11 - $208.62 $10,968 - $13,143	63 Added 0.92%	6,939 $1.34 Million
Q2 2019 Jul 11, 2019	SELL	$166.7 - $195.41 $219,377 - $257,159	-1,316 Reduced 16.06%	6,876 $1.27 Million
Q1 2019 Apr 12, 2019	SELL	$180.87 - $203.88 $2.01 Million - $2.26 Million	-11,105 Reduced 57.55%	8,192 $1.56 Million
Q4 2018 Jan 15, 2019	BUY	$178.4 - $208.25 $1.89 Million - $2.2 Million	10,580 Added 121.37%	19,297 $3.76 Million
Q3 2018 Oct 18, 2018	SELL	$185.29 - $208.89 $78,933 - $88,987	-426 Reduced 4.66%	8,717 $1.81 Million
Q2 2018 Jul 11, 2018	SELL	$166.05 - $186.51 $267,838 - $300,840	-1,613 Reduced 15.0%	9,143 $1.69 Million
Q1 2018 Apr 11, 2018	SELL	$169.43 - $198.0 $2.51 Million - $2.93 Million	-14,789 Reduced 57.89%	10,756 $1.83 Million
Q4 2017 Jan 10, 2018	BUY	$168.79 - $188.59 $47,936 - $53,559	284 Added 1.12%	25,545 $4.44 Million
Q3 2017 Oct 12, 2017	BUY	$167.29 - $191.0 $4.23 Million - $4.82 Million	25,261	25,261 $4.71 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Citizens Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on First Citizens Bank & Trust CO with notifications on news.

Account

First Citizens Bank & Trust CO Amgen Inc Transaction History